Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-EN | Version v2-FR | |
---|---|---|
Language | English | French |
Date Updated | 2024-08-07 | 2024-06-13 |
Drug Identification Number | 02460955 | 02460955 |
Brand name | CASPOFUNGIN FOR INJECTION | CASPOFUNGIN FOR INJECTION |
Common or Proper name | Caspofungin Acetate for Injection | Caspofungin Acetate for Injection |
Company Name | JUNO PHARMACEUTICALS CORP. | JUNO PHARMACEUTICALS CORP. |
Ingredients | CASPOFUNGIN | CASPOFUNGIN |
Strength(s) | 70MG | 70MG |
Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 70 mg/vial - 1 vial per carton | 70 mg/vial - 1 vial per carton |
ATC code | J02AX | J02AX |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2024-06-14 | 2024-06-14 |
Actual start date | 2024-06-14 | 2024-06-14 |
Estimated end date | 2024-08-31 | Unknown |
Actual end date | 2024-08-06 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Delays in QC testing schedules | Delays in QC testing schedules |
Health Canada comments |